Nitric oxide (NO) regulates basal CBF. In a num ber of animal models NO has been implicated in the mediation of the regional changes in CBF (rCBF) that accompany neu ronal activation (vasoneuronal coupling). However. some re sults in animal models have failed to confirm this finding. and the validity of extrapolation to man from animal data is uncer tain. To determine the contribution of NO to basal global CBF and activation-induced changes in rCBF, the authors have per formed quantitative H Z I50 positron emission tomography (PET) studies before and after administration of the non isoform-specific NO synthase inhibitor, Af3 -monomethyl-L arginine (L-NMMA), in 10 healthy male volunteers. Leaming a novel sequence of finger movements was used as a paradigm to induce regional frontal cortex activation. The effect of NO synthase inhibition on the magnitude and pattem of activation
Summary: Nitric oxide (NO) regulates basal CBF. In a num ber of animal models NO has been implicated in the mediation of the regional changes in CBF (rCBF) that accompany neu ronal activation (vasoneuronal coupling). However. some re sults in animal models have failed to confirm this finding. and the validity of extrapolation to man from animal data is uncer tain. To determine the contribution of NO to basal global CBF and activation-induced changes in rCBF, the authors have per formed quantitative H Z I50 positron emission tomography (PET) studies before and after administration of the non isoform-specific NO synthase inhibitor, Af3 -monomethyl-L arginine (L-NMMA), in 10 healthy male volunteers. Leaming a novel sequence of finger movements was used as a paradigm to induce regional frontal cortex activation. The effect of NO synthase inhibition on the magnitude and pattem of activation Vasoneuronal coupling describes the characteristic ability of the cerebral vasculature to match rapidly, and in a spatially restricted manner, regional CBF (rCBF) with neuronal activation. The mediator underlying this coupling process remains uncertain: it is not coupled to oxidative metabolism (Fox et aI., 1984) and is not ad equately explained by changes in levels of perivascular adenosine (Northington et aI., 1992) , tissue P02 (Frahm et aI., 1996) or pH (Leniger-Follert, 1984) , potassium shifts, or perivascular neurotransmitter release (Iadecola, 1993) . Recently it has been suggested that nitric oxide (NO) plays a role (Iadeco1a, 1993) . Nitric oxide is a was determined. Resting global CBF fell from 33.3 ± 5.3 mL·IOO g-I'min-I at rest before L-NMMA, to 26.5 ± 7.7 mL'IOO g-l'min-I after L-NMMA (P = 0.001). This fall was reversed by L-arginine administration. Leaming sequential fin ger movements induced increases in rCBF in the left motor, right prefrontal, and bilateral premotor cortices. After NO syn thase inhibition with L-NMMA. there was no change in this pattem of activation and no reduction in the magnitude of rCBF responses at the foci of maximal stimulation before and after L-NMMA. These findings confirm that NO production contrib utes to basal CBF regulation in man, but show that systemic NO synthase inhibition with L-NMMA does not impair re gional vasoneuronal coupling. Key Words: Nitric oxide Cerebral blood flow-Positron emission tomography Cerebral activation-Man. rapidly diffusible relaxant mediator, generated by en zymes constitutively expressed by the endothelium and neurons (Edelman and GaIly, 1997) . Studies using NO synthase inhibitors in both animals and man have dem onstrated the importance of NO in maintaining basal CBF (Iadecola et aI., 1994) . A number of studies with NO synthase inhibitors in rodents have shown inhibition of the cortical rCBF increase in response to vibrissal stimulation (Dirnagl et aI., 1993) but other studies have failed to replicate this finding (Wang et aI., 1993) . Re cent work with NO synthase isoform knockout mice sug gests that neuronally derived NO is the prime mediator of vasoneuronal coupling (Ma et aI., 1996) .
The human circulation has unique features, which in clude an extensive intracranial-extracranial collateraliza tion and the need to supply a highly developed neocor tex. This makes direct extrapolation of findings from animal studies difficult. Blood flow in peripheral vascu lar beds in man is NO-dependent (Vallance et at., 1989) , and we have recently demonstrated that human internal and common carotid artery flow is reduced by NO syn-thase inhibition (White et aI., 1998) . To test the hypoth esis that NO contributes to vasoneuronal coupling we have used the non-isoform-selective NO synthase inhibi tor, � -monomethyl-L-arginine (L-NMMA), and mea sured rCBF with H2 1 5 0 positron emission tomography (PET) in healthy volunteers. Learning a novel sequence of finger movements was used as a paradigm to induce motor, prefrontal, and premotor cortical activation (Jen kins et aI., 1994) , and statistical parametric mapping (SPM) (Friston et aI., 1995b ) was used to determine the effect of NO inhibition on the pattern and magnitude of frontal activation.
METHODS

Subjects
Ten healthy male volunteers were studied, 37.2 ± 4.2 years of age and weighing 85.1 ± 8.5 kg (mean ± SD). Local Hospital Ethics Committee approval was obtained for the study and all subjects gave informed written consent. Permission to admin ister radioactive H2150 was given by the Administration of Radioactive Substances Advisory Committee of the Depart ment of Health, United Kingdom.
Chemicals �-Monomethyl-L-arginine hydrochloride was provided by Glaxo Wellcome PLC. (Sterenage, U.K.). as a sterile solution of 100 mg/mL and was of 99.98% purity by weight. L-Arginine was prepared by our pharmacy department from lyophilized solid as a 20-mg/mL solution (99.9% purity). Sterile 0.9% sa line solution was used as a placebo and diluent. '
Data acquisition and CBF measurement
Measurements of rCBF were performed using a CTI 953B PET camera (eTI/Siemens), with interplane septa retracted to acquire data in three-dimensional mode, and a low-energy win dow was used to measure scatter. Data were acquired simulta neously over 31 planes within the camera's 1O.65-cm axial field of view. Backprojection and filtering with a Hanning filter (0.5 cycles/pixel) produced an image resolution of 8.5 x 8.5 x 4.3 mm full-width half-maximum (FWHM) after reconstruc tion. Images were displayed as a matrix of 128 x 128 x 31 voxels. Scans were acquired after a 20-second intravenous bo lus of 11.5 mCi of oxygen-15-labeled water (H2 150) in 3 mL of isotonic saline, given via an antecubital fossa vein. Time frames comprised a 30-second background frame, started ap proximately 5 seconds before the point of rise in head counts, followed by five frames of 7 seconds, two of 30 seconds, one of 90 seconds, and one of 180 seconds. Peak head counts oc curred 30 to 40 seconds after head count rise. To enable quan titative rCBF analysis arterial whole blood 150 activity was continuously measured using an on-line detection system with blood withdrawn continuously through a radial artery cannula at a rate of 5 mUmin. After each rCBF measurement, 15 min utes was allowed to elapse to ensure decay of any residual 150 nuclide before the next scan. A total of six to eight dynamic CBF scans were performed for each subject.
Activation paradigm
Scans were performed under two different experimental con ditions: a baseline rest condition and an activation condition during which a novel sequence of finger movements was learned by trial and error (Jenkins et aI., 1994) . The activation paradigm required subjects to learn sequences of keypresses eight moves long, previously programmed into a personal com puter, using a keypad with four keys corresponding to the fin gers of the right hand. The keypad was linked to an Amiga 2000 computer, which prompted a finger movement every 3 seconds and indicated by high and low tones whether a subject had selected the correct key in the sequence (Jenkins et aI., 1994) . It also monitored subject performance in terms of re sponse time and number of errors. The preprogrammed se quences were the same for all 10 subjects.
Before the subjects were positioned within the scanner they were given an opportunity to familiarize themselves with the paradigm by learning a sequence of finger movements that was not repeated during the actual study. Subjects had either three or four activation scans interspersed with rest scans. To control for auditory input during the activation study the Amiga com puter was set to generate random prompt and feedback tones during the rest condition.
The scans were performed in the following order: rest, acti vation, rest, activation, rest, activation. The first four scans were performed during an infusion of isotonic saline via the left antecubital fossa. Before the fifth scan 10 mg/kg L-NMMA was administered as a 30-second intravenous bolus and then a 1O-mg'kg-I'h-1 infusion of L-NMMA was commenced via a left antecubital fossa vein. In previous studies of the adminis tration of intravenous L-NMMA the maximal effect on sys temic blood pressure and carotid artery volume flow has been found between 5 and 10 minutes after administration (White et aI., 1998) ; therefore, the fifth scan was delayed until this time after the dose had elapsed. All subjects had six rCBF measure ments, after which the effects of L-NMMA were reversed by giving a molar excess of L-arginine (30 mg/kg) as a slow in travenous injection for 60 to 90 seconds. In 7 of these 10 subjects a further paired rest and activation scan were then performed.
All scans were performed in a darkened room with the sub ject's eyes closed. Subjects were studied in a supine position, with head position maintained by a molded, cushioned head support. Axial positioning with a plane passing through the anterior and posterior clinoid processes was achieved by align ment of line markings drawn on the forehead and orbitomeatal lines with laser lines projected perpendicularly from the scan ner gantry. Final axial head positioning to include the cerebral vertex in the field of view was performed after a short trans mission scan. Before the emission data acquisition, a 20-minute transmission scan was performed to correct for tissue attenua tion.
Data analysis
All calculations and image transformations were performed on a Sun SPARC 5 workstation (Sun Computers Inc.) using Analyze version 7.0 image display software (BRU, Mayo Foundation). Functional parametric images of CBF were gen erated essentially as described by Lammertsma et al. (1990) . Integral images, formed from the summation of the counts collected in frames 2 through 10 (30 through 150 seconds, see above), were transformed to CBF using a lookup table. The lookup table was generated from the measured arterial input function with corrections for delay and dispersion during the on-line assay of radioactivity in blood. Delay and dispersion were estimated by fitting the total count rate from the scanner to a flow model with an exponential dispersion term (Lam mertsma et aI., 1990) . Global CBF was determined from whole brain regions of interest excluding lateral ventricles, drawn on nine central transaxial planes of the CBF images. The observed estimates of global flow (see Results) were low relative to those obtained with classic methods. This may reflect a systematic bias arising from gray and white matter heterogeneity in the images, and also from the estimates of dispersion in the blood collection protocol (Lammertsma et a!., 1990) . It should be noted, however, that the present study was concerned with changes in regional flow and not just the absolute values.
Significant rCBF changes were localized using statistical parametric mapping software (SPM 95, Wellcome Depart ment of Cognitive Neurology, London, U.K.), implemented in Matlab (Mathworks Inc.). Dynamic H21S0 scans for each in dividual were realigned on a voxel-by-voxel basis using an automated realignment program based on six-parameter rigid body transformations with a least-squares technique (Friston et a!., 1995a) . This generated an aligned set of images and a mean image (each of 31 planes) for each subject. For each subject, the mean image, having the most anatomic detail, was trans formed into standard stereotactic space using linear, quadratic, and nonlinear three-dimensional deformation on a slice-by slice basis (Friston et a!., 1995a) . The same transformations were then applied to each of the subjects' realigned images to allow intersubject averaging. Transformed scans consisted of 26 planes with voxel dimension 2 x 2 x 4 mm, corresponding to the atlas of Talairach and Tournoux (1988) . Smoothing was performed using an isotropic Gaussian filter of 20 mm to in crease signal-to-noise ratio and to allow for the variation in intersubject gyral anatomy. Relative differences in basal and activated rCBF before and after L-NMMA were localized after proportional scaling, which normalized mean global CBF. This procedure generated adjusted mean rCBF values for each of the conditions (rest and activation without L-NMMA; rest and ac tivation with L-NMMA). The location of significant activity in different brain regions during performance of the motor task both before and after L-NMMA was determined by comparison of the activation with rest image using the Student's t statistic. This generated statistical parametric maps (SPM) which were subsequently converted to (SPM) maps for display. The thresh old of the SPM maps was set at P < 0. 01 (uncorrected) for display purposes to show areas of activation associated with each comparison in three orthogonal planes. Uncorrected thresholding was used to provide greater power to eliminate false negatives when searching for effects of L-NMMA on local activation changes. Corrected P values were applied to demonstrate the activation associated with the motor learning paradigm. In the comparison of activation with rest, significant results (P < 0.05) were displayed after corrections for multiple non-independent comparisons. The level of significance of these areas were characterized by their peak height, using es timations from the Theory of Gaussian Fields.
In two subjects an acquisition error led to the second rest scan before L-NMMA not being available for analysis. There fore in all 10 subjects the first rest and activation scan and the post-L-NMMA rest and activation scan were analyzed; how ever the second rest and activation pair were only available for analysis in eight subjects. Results given in the text section are from all 10 pairs for comparisons when all 10 scans in th e pair were available and for 8 pairs when comparisons included the second rest scan.
Changes in rCBF during the motor task were measured from the peak areas of activation using normalized values from the SPM matrix. Estimations of the smallest difference in the mag nitude of the activation-induced rCBF change that could be detected at the 95% confidence limit were generated from a power calculation on the basis of the standard error of the contrasts in the SPM matrix and mean differences in corrected activation-induced rCBF changes before and after L-NMMA.
In addition a region-of-interest analysis was performed to compare rest before and after L-NMMA. This was performed by application of a standardized magnetic resonance imaging based template, subdivided into regions of interest, and applied to the realigned and normalized CBF images. Regional CBF data thus generated were then proportionally scaled for changes in global CBF using the scaling factor generated within the SPM analysis, to generate a relative rCBF value. These were compared by paired t test.
Systemic hemodynamic variables
Mean arterial blood pressure was measured by an automated arm cuff (Dynamap) and pulse rate by a three-lead ECG rhythm strip. Three measures of arterial blood pressure and three 30second rhythm strips were acquired before and after each dose or scan, and mean values are presented.
RESULTS
Global cerebral blood flow
Global CBF values during rest and activation condi tions before and after L-NMMA are illustrated in Fig. 1 . Infusion of L-NMMA resulted in a significant fall in global CBF: CBF fell from 33.3 ± 5.3 mL·100 g-I 'min-I during rest before L-NMMA, to 26.5 ± 7.7 mL· 100 g-I 'min-I after L-NMMA (P = 0.001). Before L NMMA administration there was no difference in global CBF during the rest and activation periods (33.3 ± 5.3 versus 35.3 ± 5.5 mL·100 g-I 'min-1 ; P = 0.263). After L-NMMA administration, global CBF during activation was higher than that during the preceding rest period (3 1.4 ± 5.8 versus 26.5 ± 7.7 mL·100 g-I 'min-I ; P = 0.038).
In those seven subjects who received L-arginine and then underwent further scans global CBF returned to pre-L-NMMA levels. Mean global CBF increased from 31. 1 ± 6.4 mL·IOO g-I 'min-I (activation after L NMMA) to 34.0 ± 5.9 mL·I00 g-I 'min-I (P = 0.067);
this was similar to the rest CBF before L-NMMA, 35.0 ± 8.0 mL·lOO g-I 'min-I (P = 0.549).
Global Cerebral
.. Global CBF values (mean ± SO) during rest and activa tion conditions before and after L-NMMA in eight subjects in whom complete data were available.
Blood Flow
Activation-induced rCBF changes
The areas in which there were significant rCBF changes after activation (P < 0.05, corrected) are listed in Table 1 . No significant differences in rCBF were ob served before and after L-NMMA comparing the rest condition using either the SPM analysis or the region of-interest analysis, even at an uncorrected threshold of P < 0.01. Region-of-interest CBF relative to global CBF values are given in Table 2 .
Increases Comparing activation versus rest before L NMMA, the cortical areas of significantly increased blood flow were the left motor cortex, right prefrontal cortex (area 9), right and left premotor cortices (area 6), and left parietal area 40. No significant differences in activation versus rest were observed in rCBF after L NMMA compared with before L-NMMA.
The increases or decreases in normalized rCBF after activation are given in Table 1 . These are measured at the peak focus of activation. Notably, after L-NMMA, the rCBF values were consistently greater than the before L-NMMA values. Our study had 95% power at a P value of 0.05 uncorrected to detect a 5% reduction in the ac tivation-induced rCBF increase in the left premotor cor tex, and a 9% reduction in the activation-induced rCBF increase in the right premotor cortex.
Decreases A significant reduction in occipital lobe rCBF was observed during activation compared with rest before L-NMMA. Peak activation reduction in normal ized rCBF was observed in left area 18. Again no dif ference in rCBF was observed comparing activation be fore L-NMMA with activation after L-NMMA.
The study had 95% power to detect a 15% reduction in the activation-induced rCBF decrease in left area 18 at a significance level of 0.05 (uncorrected) .
Task performance During scanning no omissions in motor sequencing were made by the subjects. One sub ject managed to learn one of the sequences to the point of being able to reproduce it without errors during PET whereas a further subject managed to learn two se-quences. Increased skill at performance took place across the sequences with a reduction in errors and decreased response times. No significant difference in response times (0.65 ± 0. 17 and 0.65 ± 0.16 seconds) or total number of errors (21.5 ± 3.2 and 21.4 ± 4.8) was ob served during task performance before and after L NMMA, respectively.
Systemic hemodynamic response
After L-NMMA there was an increase in blood pres sure: rest before L-NMMA, 84.0 ± 8.2 mm Hg versus rest after L-NMMA, 103.6 ± 12.3 mm Hg; P < 0.001. Blood pressure remained significantly elevated during activation after L-NMMA at 99.7 ± 12.6 mm Hg, but this was significantly less than the arterial blood pressure during rest after L-NMMA (P = 0.038).
After L-NMMA there was a reduction in pulse rate from 61.1 ± 9.0 beats/min (rest before L-NMMA) to 47.1 ± 7.2 beats/min (rest after L-NMMA) (P < 0.001). Pulse rate remained reduced during activation after L-NMMA at 49.1 ± 6.7 beats/min; this was not significantly differ ent from the rest after L-NMMA pulse rate (P = 0.222).
In those 7 subjects who received L-arginine, arterial blood pressure and pulse rate were normalized. Arterial blood pressure fell from 98.3 ± 14.1 mm Hg (before L-arginine) to 90.4 ± 10.4 mm Hg (after L-arginine) (P = 0.006). Pulse rate increased from 48.2 ± 7.4 beats/min (before L-arginine) to 55.6 ± 9.1 beats/min (after L arginine) (P = 0.001).
DISCUSSION
In this study inhibition of NO synthase with L-NMMA resulted in a 20% fall in global CBF. In those subjects who received L-arginine, basal CBF returned to normal, confirming specificity for the NO pathway. This is con sistent with a large number of studies in animals (ladecola et aI., 1994) and a previous study in man (White et aI., 1998) . It has been suggested that there may be a regional variation in sensitivity of resting rCBF to NO synthase inhibition; in the cat, maximal rCBF reduc tion occurs in the pituitary and cerebellum (Kovach et aI., 1992) . However, for the brain regions within the field of view for this study, we did not find any regional difference in resting cortical rCBF sensitivity to NO syn thase inhibition, even at a threshold of P < 0.0 I uncor rected.
We found no reduction in the rCBF increase associ ated with a brain activation paradigm after L-NMMA administration. The sequence learning paradigm that we used in this study has been reported to result in a char acteristic pattern of regional neuronal activation, with increased rCBF in the left motor, right and left premotor, and right prefrontal cortices, and reduced occipital cortex rCBF (Jenkins et aI., 1994) . Our results were consistent with this pattern of rCBF change. Systemic NO synthase inhibition did not alter the pattern or degree of this rCBF response. Statistical power calculations estimated that we should have been able to detect a 5% reduction in rCBF in premotor cortex activation after L-NMMA, implying that there was little likelihood of missing an effect of NO synthase inhibition on activation-induced rCBF. There was no objective change in levels of arousal or vigilance, which have been reported to fall after NO synthase in hibition (Dzoljic et aI., 1997) , as there was a similar frequency of errors and mean response rates recorded before and after L-NMMA.
The effect of NO synthase inhibition on vasoneuronal coupling has been examined in several animal models of regional neuronal activation. Superfusion of rat cerebral cortex with NO synthase inhibitors abolished the global, noncortical neuronal activation-dependent CBF increase observed after cerebellar fastigial stimulation in the rat (Iadecola et aI., 1987) , and the coordination of flow and metabolism coupling in a cat model of cortical spreading depression (Goadsby et aI., 1992) . The somatosensory rCBF increase after vibrissal stimulation in rats has been reported to be reduced (Dirnagl et aI., 1993) or unaltered (Wang et aI., 1993) after systemic or topically applied NO synthase inhibition. However, other similar experi ments have failed to confirm this finding. Interpretation of the results of animal studies is made more difficult by the use of anesthetic agents. The NO synthase inhibitor, 7-nitroindazole, which has been suggested to have speci ficity for the neuronal isoform, has been reported to re duce both basal and stimulus-evoked flow increases without altering neuronal metabolism (Cholet et aI., 1997) . However, interpretation of these results is com plicated by studies suggesting that 7-nitroindazole inhib its both endothelial and inducible isoforms of NO syn thase as well as the neuronal isoform (Bland ward and Moore, 1995) . Studies in endothelial and neuronal NO synthase knockout mice implicate neuronally derived NO as the mediator of stimulus-evoked rCBF increases (Ma et a!., 1996) . However, interpretation of these results is complicated by the possibility of other compensatory pathways developing to subserve for any NO absence. Indeed one of the most striking features of NO synthase knockout mice is the normality of their cerebrovascular physiology (Irikura et a!., 1995) . The observation that the glutaminergic neurotransmitter system can increase rCBF via NO-dependent mechanisms provides for a po tential link between regional neuronal activity and blood flow (Faraci and Bresse, 1993) .
To ensure continuous sustained inhibition of NO syn thase we followed the bolus of L-NMMA with a main tenance intravenous infusion. However, it is possible that there may have been a lesser degree of NO synthase inhibition during the post-L-NMMA activation paradigm compared with the preceding resting scan. The observa tion that global CBF values were higher during activa tion compared with rest after L-NMMA is consistent with this. Nevertheless, the resting CBF and systemic hemodynamic indices were still significantly altered at this time, suggesting that there was significant endothe lial NO synthase inhibition.
A potential problem with the use of L-arginine analogs to inhibit NO synthase is blood-brain barrier penetration. After bolus L-NMMA administration in man there is a rapid increase in arterial blood pressure, which is closely mirrored by reductions in basal internal carotid artery flow (White et a!., 1998) , suggesting effective endothe lial NO synthase inhibition. However, the degree to which L-NMMA inhibits neuronal NO synthase in man is not known. Cationic amino acid transporters have been characterized but are relatively slow (Stoll et a!., 1993) , and there is evidence that total brain NO synthase inhi bition is dose-and time-dependent (Traystman et aI., 1995) . To maximize the likelihood of neuronal NO syn thase inhibition, we used the largest doses of L-NMMA previously given to healthy volunteers, a dose that pro duces substantial changes in blood pressure. Without a specific neuronal NO synthase inhibitor, or direct quan tification of either brain L-NMMA levels or the degree of brain neuronal NO synthase inhibition, it is not pos sible to exclude a role for neuron ally derived NO in mediating vasoneuronal coupling on the basis of our data. However, our results imply that endothelial NO synthase plays little role in vasoneuronal coupling. A role for neuronal NO synthase cannot be excluded until an isoform-specific neuronal NO synthase inhibitor with good blood-brain barrier penetration is available; such an inhibitor is not currently available for use in man.
